| Document Date: 2009-03-31 11:11:51
Open Document File Size: 72,35 KBShare Result on Facebook
City Newark / Syracuse / King Of Prussia / / Company DuPont Co. / Bristol-Myers Squibb / GlaxoSmithKline / / / Facility Commonwealth University of Virginia / / / IndustryTerm immunomodulatory chemicals / test systems / pharmaceuticals / chemicals / chemical and pharmaceutical industry / industrial chemicals / / MedicalCondition delayed-type hypersensitivity / PFA / / MedicalTreatment immunosuppression / / Organization FDA / University of Virginia / MHLW / Immunotoxicology Technical Committee / EMEA / Environmental Protection Agency / / Person Role / Pres Type / Danuta J. Herzyk / Kimber L. White / Michael Holsapple / Peter J. Bugelski / Helen G. Haggerty / / / Position CHAIR / Co-chair / / Product azathioprine / dexamethasone / cyclophosphamide / / Technology antibodies / /
SocialTag |
CONTROL ID: [removed]PRESENTATION TYPE: Workshop Secondary Pres Type - Proposal: IAT/ITS Designation: TITLE: Immunotoxicity Evaluation by Immune Function Tests